Literature DB >> 32809142

Environmental Tobacco Smoke Exposure Estimated Using the SHSES Scale and Epicardial Adipose Tissue Thickness in Hypertensive Patients.

Paweł Gać1,2, Karolina Czerwińska3, Małgorzata Poręba4, Piotr Macek5, Grzegorz Mazur5, Rafał Poręba5.   

Abstract

The aim of the study was to assess the relationship between environmental tobacco smoke exposure (ETS) and epicardial adipose tissue thickness (EATT) in hypertensive patients. A total of 96 patients with essential hypertension were recruited for this study. The group consisted of 48 females and 48 males with the mean age of 69.32 ± 9.54 years. ETS was assessed with The Secondhand Smoke Exposure Scale (SHSES). EATT was assessed in 128-slice dual source coronary computed tomography angiography. In accordance to SHSES scale patients were divided into subgroups: subgroup A-no ETS exposure (SHSES = 0 points, n = 48), subgroup B-low ETS exposure (SHSES = 1-3 points, n = 11), subgroup C-medium ETS exposure (SHSES = 4-7 points, n = 20) and subgroup D-high ETS exposure (SHSES = 8-11 points, n = 17). Within the study group the mean EATT was 5.75 ± 1.85 mm and the mean SHSES score was 3.05 ± 3.74. EATT was statistically significantly higher in subgroup D than in subgroups A and B (A: 5.28 ± 1.64 mm, B: 5.04 ± 2.64 mm, D: 7.04 ± 2.64 mm, pA-D and pB-D < 0.05). There was a positive linear correlation between the exposure to ETS expressed by the SHSES scale and EATT (r = 0.44, p < 0.05). Regression analysis showed that higher SHSES score, higher BMI, and higher systolic and diastolic blood pressure are independent risk factors for higher EATT values. Contrary, the use of ACE inhibitors and β-blockers appeared to be independent protecting factor against higher EATT values. There is an unfavorable positive relationship between ETS exposure estimated using the SHSES scale and EATT in hypertensive patients.

Entities:  

Keywords:  Computed tomography; Environmental tobacco smoke; Epicardial adipose tissue; Hypertension; SHSES scale

Year:  2020        PMID: 32809142      PMCID: PMC7790793          DOI: 10.1007/s12012-020-09598-y

Source DB:  PubMed          Journal:  Cardiovasc Toxicol        ISSN: 1530-7905            Impact factor:   3.231


  33 in total

Review 1.  Epicardial adipose tissue: new parameter for cardiovascular risk assessment in high risk populations.

Authors:  Roberta Russo; Biagio Di Iorio; Luca Di Lullo; Domenico Russo
Journal:  J Nephrol       Date:  2018-04-27       Impact factor: 3.902

Review 2.  Hypertension Is a Risk Factor for Several Types of Heart Disease: Review of Prospective Studies.

Authors:  Yoshihiro Kokubo; Chisa Matsumoto
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

3.  Tobacco smoking and cytokine levels in human epicardial adipose tissue: Impact of smoking cessation.

Authors:  Lukas Mach; Helena Bedanova; Miroslav Soucek; Michal Karpisek; Petr Nemec; Marek Orban
Journal:  Atherosclerosis       Date:  2016-10-13       Impact factor: 5.162

4.  Measurements of pericardial adipose tissue using contrast enhanced cardiac multidetector computed tomography--comparison with cardiac magnetic resonance imaging.

Authors:  Marie Bayer Elming; Jacob Lønborg; Thomas Rasmussen; Jørgen Tobias Kühl; Thomas Engstrøm; Niels Vejlstrup; Lars Køber; Klaus F Kofoed
Journal:  Int J Cardiovasc Imaging       Date:  2013-05-24       Impact factor: 2.357

5.  Effects of epicardial adipose tissue volume and density on cardiac structure and function in patients free of coronary artery disease.

Authors:  Yang Lu; Tianle Wang; Rui Zhan; Xiaoyu Wang; Xiwu Ruan; Rongxing Qi; Sheng Huang
Journal:  Jpn J Radiol       Date:  2020-03-19       Impact factor: 2.374

Review 6.  Human epicardial adipose tissue: a review.

Authors:  Harold S Sacks; John N Fain
Journal:  Am Heart J       Date:  2007-06       Impact factor: 4.749

7.  Epicardial adipose tissue is related to arterial stiffness and inflammation in patients with cardiovascular disease and type 2 diabetes.

Authors:  Shaween Al-Talabany; Ify Mordi; J Graeme Houston; Helen M Colhoun; Jonathan R Weir-McCall; Shona Z Matthew; Helen C Looker; Daniel Levin; Jill J F Belch; Fiona Dove; Faisel Khan; Chim C Lang
Journal:  BMC Cardiovasc Disord       Date:  2018-02-13       Impact factor: 2.298

8.  Association between Secondhand Smoke Exposure and Hypertension in 106,268 Korean Self-Reported Never-Smokers Verified by Cotinine.

Authors:  Byung Jin Kim; Jeong Gyu Kang; Ji Hye Kim; Dae Chul Seo; Ki Chul Sung; Bum Soo Kim; Jin Ho Kang
Journal:  J Clin Med       Date:  2019-08-16       Impact factor: 4.241

9.  Serum cotinine levels and prehypertension in never smokers.

Authors:  Omayma Alshaarawy; Jie Xiao; Michael E Andrew; Cecil Burchfiel; Anoop Shankar
Journal:  Int J Hypertens       Date:  2013-02-17       Impact factor: 2.420

Review 10.  Epicardial fat: definition, measurements and systematic review of main outcomes.

Authors:  Angela Gallina Bertaso; Daniela Bertol; Bruce Bartholow Duncan; Murilo Foppa
Journal:  Arq Bras Cardiol       Date:  2013-07       Impact factor: 2.000

View more
  2 in total

1.  Short-Term Effects of Side-Stream Smoke on Nerve Growth Factor and Its Receptors TrKA and p75NTR in a Group of Non-Smokers.

Authors:  Anna Maria Stabile; Alessandra Pistilli; Desirée Bartolini; Eleonora Angelucci; Marco Dell'Omo; Gabriele Di Sante; Mario Rende
Journal:  Int J Environ Res Public Health       Date:  2022-08-19       Impact factor: 4.614

2.  Aortic Valve Calcification Score in Patients with Arterial Hypertension Environmentally Exposed to Tobacco Smoke.

Authors:  Paweł Gać; Adrian Martuszewski; Patrycja Paluszkiewicz; Małgorzata Poręba; Grzegorz Mazur; Rafał Poręba
Journal:  Cardiovasc Toxicol       Date:  2021-07-26       Impact factor: 3.231

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.